KR20200107880A - Composition for protecting skin containing oenothera biennis extract as active ingredient - Google Patents

Composition for protecting skin containing oenothera biennis extract as active ingredient Download PDF

Info

Publication number
KR20200107880A
KR20200107880A KR1020200091521A KR20200091521A KR20200107880A KR 20200107880 A KR20200107880 A KR 20200107880A KR 1020200091521 A KR1020200091521 A KR 1020200091521A KR 20200091521 A KR20200091521 A KR 20200091521A KR 20200107880 A KR20200107880 A KR 20200107880A
Authority
KR
South Korea
Prior art keywords
evening primrose
cells
primrose extract
extract
apoptosis
Prior art date
Application number
KR1020200091521A
Other languages
Korean (ko)
Other versions
KR102566548B1 (en
Inventor
정진우
이승영
김철환
박철
김기영
최영현
김상철
정상철
최경민
Original Assignee
국립낙동강생물자원관
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020180154837A external-priority patent/KR20200068780A/en
Application filed by 국립낙동강생물자원관 filed Critical 국립낙동강생물자원관
Priority to KR1020200091521A priority Critical patent/KR102566548B1/en
Publication of KR20200107880A publication Critical patent/KR20200107880A/en
Application granted granted Critical
Publication of KR102566548B1 publication Critical patent/KR102566548B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a composition for protecting skin, containing an Oenothera tetraptera extract as an active ingredient. The Oenothera tetraptera uses an aerial part thereof excluding a root part. The composition according to the present invention has no cytotoxicity, has excellent antioxidant activity due to high reducing power and DPPH radical scavenging ability, and increases the survival rate of cells by inhibiting the production of reactive oxygen species, DNA damage, apoptosis and mitochondrial membrane damage, thereby protecting the skin.

Description

달맞이꽃 추출물을 유효성분으로 함유하는 피부 보호용 조성물{COMPOSITION FOR PROTECTING SKIN CONTAINING OENOTHERA BIENNIS EXTRACT AS ACTIVE INGREDIENT}Skin protection composition containing evening primrose extract as an active ingredient {COMPOSITION FOR PROTECTING SKIN CONTAINING OENOTHERA BIENNIS EXTRACT AS ACTIVE INGREDIENT}

본 발명은 달맞이꽃 추출물을 유효성분으로 함유하는 피부 보호용 조성물에 관한 것이다.The present invention relates to a composition for skin protection containing an evening primrose extract as an active ingredient.

피부 노화는 자연적으로 발생하는 내인성 노화와 외부의 환경에 의해 발생하는 외인성 노화로 분류할 수 있다. Skin aging can be classified into endogenous aging that occurs naturally and exogenous aging that is caused by an external environment.

내인성 노화는 유전적 요인과 세포대사 불균형으로 발생하며, 외인성 노화는 주로 자외선 자극과 같은 외부적 자극에 의해 발생한다.Endogenous aging is caused by genetic factors and cell metabolism imbalance, and exogenous aging is mainly caused by external stimuli such as UV stimulation.

자외선에 노출되어 피부가 자극받게 되면 활성산소종 (reactive oxygen species, ROS)이 발생하는데, 활성산소종은 피부의 산화 스트레스로 인한 손상을 유도하여 피부 노화를 촉진시킨다.When the skin is irritated by exposure to UV rays, reactive oxygen species (ROS) are generated, which induces damage due to oxidative stress in the skin and promotes skin aging.

산화 스트레스로 인해 피부노화가 촉진되면 DNA 손상을 야기하며, 이러한 손상이 회복될 수 없을 정도로 심각하면 세포사멸이 유도되어 피부의 상피 구조를 파괴시키고 피부 질환을 일으킨다.When skin aging is promoted due to oxidative stress, DNA damage is caused. If such damage is severe enough to be irreparable, apoptosis is induced, destroying the epithelial structure of the skin and causing skin diseases.

이에 따라, 산화 스트레스에 의한 피부 노화 및 피부 질환을 치료할 수 있는 새로운 항산화 물질에 대한 연구 및 개발이 요구되고 있는 실정이다.Accordingly, research and development of new antioxidant substances capable of treating skin aging and skin diseases caused by oxidative stress are required.

현재까지 사용되고 있는 항산화제는 부티레이트 하이드록시톨루엔 (butylated hydroxytoluene, BHT)이 있지만, 최근 동물실험에서 기형 발생 또는 암 발생에 관여하는 것으로 보고되어 BHT를 사용함에 있어서 문제되고 있다.Antioxidants that have been used up to now include butyrate hydroxytoluene (BHT), but it has been reported to be involved in the occurrence of malformations or cancer in recent animal experiments, and thus there is a problem in the use of BHT.

따라서, 부작용이 개선되어 인체에 흡수되도 안전하며, 항산화 효과가 뛰어난 항산화물질을 개발하기 위한 연구가 필요한 실정이다.Therefore, there is a need for research to develop antioxidants that are safe to be absorbed by the human body due to improved side effects, and have excellent antioxidant effects.

한편 본 발명자는 달맞이꽃 추출물을 이용하여 세포독성이 낮으며 항산화 활성이 뛰어난 피부 보호용 조성물을 개발하고자 하는 바, 달맞이꽃에 대해 살펴보면 다음과 같다.Meanwhile, the present inventor intends to develop a composition for skin protection with low cytotoxicity and excellent antioxidant activity by using an evening primrose extract. Looking at the evening primroses as follows.

달맞이꽃 (Oenothera biennis)은 바늘꽃과의 2년생초본으로 야래향 또는 월하향으로도 불리며, 우리 나라 전국 각지에서 찾아볼 수 있다.Evening primrose ( Oenothera biennis ) is a biennial herb of the needle flower family. It is also called Yaraehyang or Wolhahyang, and can be found all over Korea.

한방에서는 뿌리를 월견초라고 하여 감기로 열이 높고 인후염이 있을 때 물에 넣고 달여서 복용하고, 종자를 월견자라고 하여 고지혈증에 사용한다.In oriental medicine, the root is called Wolgyeoncho, and when you have a cold and sore throat, put it in water and take it after decoction.

달맞이꽃과 관련된 선행기술에 대해 살펴보면, 대한민국 등록특허공보 제10-1892626호에는 "달맞이꽃 추출물을 유효성분으로 포함하는 알레르기성 질환의 예방 또는 개선용 조성물"에 대해 기재되어 있다.Looking at the prior art related to evening primrose, Korean Patent Publication No. 10-1892626 describes "a composition for preventing or improving allergic diseases comprising an evening primrose extract as an active ingredient".

그러나 상기 선행기술과 본 발명을 비교해보면, 달맞이꽃을 사용한다는 점에서는 유사하나, 본 발명은 달맞이꽃을 사용하여 산화 스트레스로부터 피부를 보호하기 위해 사용한다는 점에서 효과가 상이하다.However, when comparing the prior art with the present invention, it is similar in that an evening primrose is used, but the effect of the present invention is different in that the evening primrose is used to protect the skin from oxidative stress.

이에 따라, 본 발명은 달맞이꽃의 지상부 (arial part) 추출물이 인간 피부각질세포의 산화 스트레스에 의한 손상을 억제하는데 효과적이라는 것을 발견하여 본 발명을 완성하게 되었다.Accordingly, the present invention has completed the present invention by finding that the extract of the arial part of the evening primrose is effective in suppressing the damage caused by oxidative stress in human keratinocytes.

대한민국 등록특허공보 제10-1892626호 (2018.08.22)Republic of Korea Patent Publication No. 10-1892626 (2018.08.22)

본 발명의 목적은 달맞이꽃 추출물을 유효성분으로 함유하는 피부 보호용 조성물을 제공하고자 한다.It is an object of the present invention to provide a composition for skin protection containing an evening primrose extract as an active ingredient.

보다 상세하게는, 세포독성이 없고, 환원력 및 DPPH 라디칼 소거능이 높아 항산화 활성이 뛰어나며, 활성산소종 생산, DNA 손상, 세포사멸 및 미토콘드리아 막 손상을 억제하여 세포의 생존율을 증가시키는 효과를 갖는 달맞이꽃 추출물을 유효성분으로 함유하는 피부 보호용 조성물을 제공하고자 한다.More specifically, it has no cytotoxicity, high reducing power and DPPH radical scavenging ability, so it has excellent antioxidant activity, and has the effect of increasing the survival rate of cells by inhibiting the production of reactive oxygen species, DNA damage, apoptosis and mitochondrial membrane damage. It is intended to provide a composition for skin protection containing as an active ingredient.

본 발명은 달맞이꽃 추출물을 유효성분으로 함유하는 것을 특징으로 하는 피부 보호용 조성물을 제공함으로써 기술적 과제를 해결하고자 한다.The present invention is to solve the technical problem by providing a composition for skin protection, characterized in that it contains an evening primrose extract as an active ingredient.

상기 달맞이꽃은 뿌리부를 제외한 지상부인 것을 특징으로 한다.The evening primrose is characterized in that the above-ground portion excluding the root portion.

상기 달맞이꽃 추출물의 처리 농도는 인간 피부각질세포 (HaCaT) 3 x 105 cells/ml에 50~70 ug/ml인 것을 특징으로 한다.The treatment concentration of the evening primrose extract is characterized in that 50 to 70 ug/ml in 3 x 10 5 cells/ml of human keratinocytes (HaCaT).

상기 조성물은 세포독성이 없고, 환원력 및 DPPH 라디칼 소거능이 높아 항산화 활성이 뛰어나며, 활성산소종 생산, DNA 손상, 세포사멸 및 미토콘드리아 막 손상을 억제하여 세포의 생존율을 증가시키는 것을 특징으로 한다.The composition has no cytotoxicity, high reducing power and DPPH radical scavenging ability, so it has excellent antioxidant activity, and inhibits the production of reactive oxygen species, DNA damage, apoptosis, and mitochondrial membrane damage, thereby increasing the survival rate of cells.

또한, 본 발명은 달맞이꽃을 유효성분으로 함유하는것을 특징으로 하는 화장료 조성물 또는 건강기능식품 조성물을 제공한다.In addition, the present invention provides a cosmetic composition or a health functional food composition, characterized in that it contains evening primrose as an active ingredient.

본 발명에 따른 달맞이꽃 추출물을 유효성분으로 함유하는 피부 보호용 조성물은, 세포독성이 없고, 환원력 및 DPPH 라디칼 소거능이 높아 항산화 활성이 뛰어나며, 활성산소종 생산, DNA 손상, 세포사멸 및 미토콘드리아 막 손상을 억제하여 세포의 생존율을 증가시키는 효과를 보유하고 있다.The composition for skin protection containing the evening primrose extract according to the present invention has no cytotoxicity, has high reducing power and DPPH radical scavenging ability, has excellent antioxidant activity, and inhibits the production of reactive oxygen species, DNA damage, apoptosis and mitochondrial membrane damage. Thus, it has the effect of increasing the survival rate of cells.

도 1은 달맞이꽃 추출물이 HaCaT 세포의 생존율에 미치는 효과를 나타낸 도면으로, (a)는 달맞이꽃 추출물을 다양한 농도로 처리하였을 때의 HaCaT 세포의 생존율에 미치는 효과를 나타낸 그래프이며, (b)는 달맞이꽃 추출물이 과산화수소 처리하여 산화 스트레스를 유도한 HaCaT 세포의 생존율에 미치는 효과를 나타낸 그래프이다.
도 2는 달맞이꽃 추출물의 환원력 및 DPPH 라디칼 소거능을 나타낸 도면으로, (a)는 달맞이꽃 추출물의 환원력을 나타낸 그래프이며, (b)는 달맞이꽃 추출물의 DPPH 라디칼 소거능을 나타낸 그래프이다.
도 3은 달맞이꽃 추출물이 과산화수소를 처리하여 산화 스트레스를 유도한 HaCaT 세포의 활성산소종 생산에 미치는 효과를 나타낸 도면으로, (a)는 HaCaT 세포의 활성산소종 생산정도를 나타낸 현광현미경 사진이고 (200배율), (b) 활성산소종의 생산정도를 유세포측정기로 측정한 결과를 나타내는 그래프이고, (c)는 현광현미경에서 측정된 형광발현정도를 나타낸 그래프이고, (d)는 활성산소종의 생산정도를 나타낸 그래프이다.
도 4는 달맞이꽃 추출물이 과산화수소를 처리하여 산화 스트레스를 유도한HaCaT 세포의 comet 생성에 미치는 영향을 나타낸 도면으로, (a)는 comet의 생성정도를 나타낸 현광현미경 사진이며, (b)는 comet 꼬리의 운동 (tail moment, TM)을 측정한 그래프이며, (c)는 comet 꼬리의 길이 (tail length, TL)를 측정한 그래프이다.
도 5는 달맞이꽃 추출물이 과산화수소를 처리하여 산화 스트레스를 유도한 HaCaT 세포의 단백질 발현에 미치는 영향을 나타낸 도면으로, (a)는 γH2AX 및 인산화된 γH2AX의 발현정도를 나타낸 전기영동 사진이며, (b)는 γH2AX 발현정도에 따른 인산화된 γH2AX 단백질의 비율의 변화를 나타낸 그래프이며, (c)는 caspase-3 및 PARP의 활성화정도를 나타낸 전기영동 사진이며, (d)는 달맞이꽃 추출물의 처리 시간에 따른 keap1, Nrf2 및 HO-1의 발현정도를 나타낸 전기영동 사진이다.
도 6은 달맞이꽃 추출물이 과산화수소를 처리하여 산화 스트레스를 유도한 HaCaT 세포의 미토콘드리아 막 전위에 미치는 영향을 나타낸 도면으로, (a)는 JC-1 응집체가 JC-1 단량체로 변하는 정도를 유세포측정기로 측정하여 나타낸 그래프이며, (b)는 JC-1 응집체가 JC-1단량체로 변하면서 달라지는 붉은색 형광값을 나타낸 그래프이다.
도 7은 달맞이꽃 추출물이 과산화수소를 처리하여 산화적 스트레스가 유도된 HaCaT 세포의 사멸에 미치는 영향을 나타낸 도면으로, (a)는 4',6'-디아미노-2-페닐인돌 (4',6'-diamidino-2-phenylindol, DAPI)로 염색한 세포 핵을 촬영한 형광현미경 사진이며, (b)는 실험군과 대조군의 세포사멸정도를 측정하여 나타낸 그래프이며, (c) 세포사멸이 유도된 세포의 DNA를 추출하여 전기영동하여 DNA 절단정도를 나타낸 사진이다.
Figure 1 is a diagram showing the effect of the evening primrose extract on the survival rate of HaCaT cells, (a) is a graph showing the effect on the survival rate of HaCaT cells when the evening primrose extract is treated at various concentrations, (b) is an evening primrose extract It is a graph showing the effect of hydrogen peroxide treatment on the survival rate of HaCaT cells induced oxidative stress.
Figure 2 is a diagram showing the reducing power and DPPH radical scavenging ability of the evening primrose extract, (a) is a graph showing the reducing power of the evening primrose extract, (b) is a graph showing the DPPH radical scavenging ability of the evening primrose extract.
Figure 3 is a view showing the effect of the evening primrose extract on the production of reactive oxygen species in HaCaT cells induced oxidative stress by treatment with hydrogen peroxide, (a) is a photomicrograph showing the level of reactive oxygen species production in HaCaT cells (200 Magnification), (b) is a graph showing the result of measuring the production level of reactive oxygen species with a flow cytometer, (c) is a graph showing the degree of fluorescence expression measured by a fluorescence microscope, and (d) is the production of reactive oxygen species It is a graph showing the degree.
Figure 4 is a diagram showing the effect of the evening primrose extract on the comet generation of HaCaT cells induced oxidative stress by treatment with hydrogen peroxide, (a) is a fluorescence micrograph showing the degree of comet generation, (b) is the tail of the comet It is a graph measuring motion (tail moment, TM), and (c) is a graph measuring the length of the comet tail (tail length, TL).
5 is a view showing the effect of the evening primrose extract on the protein expression of HaCaT cells induced oxidative stress by treatment with hydrogen peroxide, (a) is an electrophoresis picture showing the expression level of γH2AX and phosphorylated γH2AX, (b) Is a graph showing the change in the ratio of phosphorylated γH2AX protein according to the level of γH2AX expression, (c) is an electrophoresis picture showing the degree of activation of caspase-3 and PARP, and (d) is keap1 according to the treatment time of evening primrose extract , Is an electrophoresis picture showing the expression level of Nrf2 and HO-1.
Figure 6 is a view showing the effect of the evening primrose extract on the mitochondrial membrane potential of HaCaT cells induced oxidative stress by treatment with hydrogen peroxide.(a) is a flow cytometer measuring the degree to which JC-1 aggregates change into JC-1 monomers And (b) is a graph showing the red fluorescence value that changes as the JC-1 aggregate changes to the JC-1 monomer.
7 is a diagram showing the effect of the evening primrose extract on the death of HaCaT cells induced by oxidative stress by treating hydrogen peroxide, (a) is 4',6'-diamino-2-phenylindole (4',6 '-diamidino-2-phenylindol, DAPI) stained cell nucleus is a fluorescence micrograph, (b) is a graph showing the degree of apoptosis in the experimental group and the control group, and (c) apoptosis induced cells This is a picture showing the degree of DNA cleavage by extracting and electrophoresis of DNA.

본 명세서 및 청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 안되며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다.Terms and words used in this specification and claims should not be construed as being limited to their usual or dictionary meanings, and that the inventor can appropriately define the concept of terms in order to describe his own invention in the best way. Based on the principle, it should be interpreted as a meaning and concept consistent with the technical idea of the present invention.

따라서 본 명세서에 기재된 실시예와 실험예는 본 발명의 가장 바람직한 일실시예에 불과할 뿐이고 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형예들이 있을수 있음을 이해하여야 한다.Therefore, the embodiments and experimental examples described in the present specification are only the most preferred embodiments of the present invention and do not represent all of the technical spirit of the present invention, and various equivalents and modifications that can replace them at the time of application It should be understood that there may be examples.

실험예 1. 달맞이꽃 추출물 준비Experimental Example 1. Preparation of evening primrose extract

경상북도 상주시에서 채집한 달맞이꽃을 물로 씻은 후 실온에서 공기 건조하였다.Evening primroses collected in Sangju, Gyeongsangbuk-do, were washed with water and air dried at room temperature.

달맞이꽃의 뿌리부를 제외한 지상부만을 선별한 뒤 분쇄기를 사용하여 분쇄하여 분말을 얻었다.After selecting only the above-ground part excluding the root part of the evening primrose, it was pulverized using a grinder to obtain powder.

분말 100 g을 에탄올 2 L에 넣고 25℃에서 24시간동안 100 rpm에서 진탕혼합하였다.100 g of the powder was added to 2 L of ethanol and mixed with shaking at 100 rpm for 24 hours at 25°C.

이렇게 얻은 달맞이꽃 추출물을 필터를 사용하여 여과하였고, 진공회전농축기 (N-1000S)를 사용하여 용매가 제거된 달맞이꽃 분말을 획득하였다.The obtained evening primrose extract was filtered using a filter, and a solvent removed evening primrose powder was obtained using a vacuum rotary concentrator (N-1000S).

달맞이꽃 분말을 디메틸설폭사이드 (dimethyl sulfoxide, DMSO)에 녹여 100 mg/ml 의 원액 (stock solution)을 제조한 후 4℃에서 보관하였다.Evening primrose powder was dissolved in dimethyl sulfoxide (DMSO) to prepare a stock solution of 100 mg/ml and then stored at 4°C.

원액은 생리식염수를 사용하여 원하는 농도로 희석시켜 실험을 진행하였다.The stock solution was diluted to a desired concentration using physiological saline, and the experiment was conducted.

아래 실시되는 모든 실험 결과는 평균값을 기초로 ±S.D.(표준편차)로 나타내었고, 결과값의 P-valus가 0.05 미만일 경우 유의한 것으로 판정하였다.The results of all experiments conducted below were expressed as ±S.D. (standard deviation) based on the average value, and if the P-valus of the result was less than 0.05, it was determined to be significant.

실험예 2. 세포 배양 및 세포 생존율분석Experimental Example 2. Cell culture and cell viability analysis

1. 세포 배양1. Cell culture

본 실험에 사용한 인간 피부각질세포 (HaCaT) 세포주는 아메리칸 타입 컬쳐 컬렉션 (American Type Culture Collection, ATCC)에서 구입하였다.The human skin keratinocyte (HaCaT) cell line used in this experiment was purchased from the American Type Culture Collection (ATCC).

HaCaT 세포를 10% 소태아 혈청 (가열하여 불활성화시킴), 스트렙토마이신 (100 μg/mL) 및 페니실린 (100 unit/mL)이 함유된 로스웰 파크 메모리얼 인스티튜트 (Roswell Park Memorial Institute, RPMI) 1640 배지를 사용하여, 이산화탄소 배양기에서 5% CO2 및 37℃를 유지하며 배양하였다.HaCaT cells were plated with Roswell Park Memorial Institute (RPMI) 1640 medium containing 10% fetal bovine serum (heated to inactivate), streptomycin (100 μg/mL), and penicillin (100 unit/mL). Using, it was cultured while maintaining 5% CO2 and 37 ℃ in a carbon dioxide incubator.

2. 달맞이꽃 추출물을 처리한 세포의 생존율 분석2. Analysis of viability of cells treated with evening primrose extract

세포 생존율을 분석하기 위해 HaCaT 세포를 6-웰 플레이트 (6-well plate)에 3 x 105 cells/ml로 접종하고 24시간 동안 배양한 후 다양한 농도의 달맞이꽃 추출물울 처리한 뒤 24시간동안 배양하였다. To analyze the cell viability, HaCaT cells were inoculated into a 6-well plate at 3 x 10 5 cells/ml, incubated for 24 hours, treated with evening primrose extracts of various concentrations, and cultured for 24 hours. .

도 1(a)는 달맞이꽃 추출물을 다양한 농도로 처리하였을 때의 HaCaT 세포의 생존율을 나타낸 그래프이다.1 (a) is a graph showing the survival rate of HaCaT cells when the evening primrose extract was treated at various concentrations.

그 결과, 달맞이꽃 추출물은 60 ug/ml 까지의 농도에서 세포 생존력에 별다른 영향을 주지 않았으나, 80 ug/ml 이상의 농도에서 세포 생존력을 점차적으로 감소시켰다.As a result, the evening primrose extract did not significantly affect cell viability at concentrations up to 60 ug/ml, but gradually decreased cell viability at concentrations of 80 ug/ml or more.

따라서, 달맞이꽃 추출물이 과산화수소 처리된 HaCaT 세포에 미치는 영향을 알아보기 위해 60 ug/ml 농도로 맞춰서 실험을 진행하였다.Therefore, in order to examine the effect of the evening primrose extract on the hydrogen peroxide-treated HaCaT cells, the experiment was conducted at a concentration of 60 ug/ml.

달맞이꽃 추출물이 과산화수소를 30분동안 처리하여 산화 스트레스가 유도된 HaCaT 세포에 미치는 영향을 알아보기 위해, 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) 분석을 수행하였다.To investigate the effect of evening primrose extract on HaCaT cells induced oxidative stress by treating hydrogen peroxide for 30 minutes, 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) analysis was performed. I did.

세포에 MTT 0.5 mg/ml를 처리한 뒤 37℃에서 3시간동안 배양하였다.After the cells were treated with 0.5 mg/ml of MTT, they were incubated at 37°C for 3 hours.

배양이 끝난 뒤, 배지를 제거하고 포르마잔 (formazan) 침전물을 디메틸설폭사이드에 용해시켰다.After the culture was completed, the medium was removed and the formazan precipitate was dissolved in dimethyl sulfoxide.

포르마잔 생성물의 흡광도를 Cytation-3 마이크로플레이트 리더 (microplate reader)를 사용하여 540 nm 파장에서 측정하였다.The absorbance of the formazan product was measured at a wavelength of 540 nm using a Cytation-3 microplate reader.

아무것도 처리되지 않은 세포를 정상군, 과산화수소 0.5 mM을 처리한 세포를 대조군1, 항산화제인 N-아세틸-L-시스테인 (N-acetyl-L-cysteine, NAC) 10 mM을 처리한 뒤 과산화수소 0.5 mM을 처리한 세포를 대조군 2, 달맞이꽃 추출물을 처리한 뒤 달맞이꽃 추출물을 처리한 세포를 실험군으로 정하였다.Cells that were not treated with anything were treated with normal group, cells treated with 0.5 mM hydrogen peroxide as control 1, antioxidant N-acetyl-L-cysteine (NAC) 10 mM, and 0.5 mM hydrogen peroxide. The treated cells were treated with the control group 2 and the evening primrose extract, and then the cells treated with the evening primrose extract were designated as the experimental group.

도 1(b)는 달맞이꽃 추출물이 과산화수소 처리하여 산화 스트레스를 유도한 HaCaT 세포의 생존율에 미치는 효과를 나타낸 그래프이다.1(b) is a graph showing the effect of the evening primrose extract on the survival rate of HaCaT cells induced oxidative stress by treatment with hydrogen peroxide.

그 결과, 과산화수소를 처리한 대조군1의 생존력은 현저하게 감소하였다.As a result, the viability of the control group 1 treated with hydrogen peroxide was significantly reduced.

그러나, 달맞이꽃 추출물을 전처리한 실험군은 NAC를 전처리한 대조군2와 마찬가지로 달맞이꽃 추출물의 농도 의존적으로 생존율이 증가하였다.However, the experimental group pretreated with the evening primrose extract increased the survival rate in a concentration-dependent manner of the evening primrose extract, as in the control group 2 pretreated with NAC.

실험예 3. 달맞이꽃 추출물의 환원력 및 DPPH 라디칼 소거능 분석Experimental Example 3. Analysis of reducing power and DPPH radical scavenging ability of evening primrose extract

1) 달맞이꽃 추출물의 환원력 분석1) Analysis of reducing power of evening primrose extract

달맞이꽃 추출물의 환원력을 분석하기 위해, Fe3+/페리시안화합물 (ferric cyanide) 복합체가 Fe2+ 형태로 환원되는 정도를 분석하였다.In order to analyze the reducing power of the evening primrose extract, the degree of reduction of the Fe 3+ / ferric cyanide complex to the Fe2 + form was analyzed.

달맞이꽃 추출물 (0~100 ug/ml)을 0.1M 인산염완충용액 (phosphate buffer, pH 6.6) 50 ml에 용해시키고, 페리시안화 칼륨 (potassium ferricyanide) 0.5 g을 첨가하여 혼합하였다.Evening primrose extract (0-100 ug/ml) was dissolved in 50 ml of 0.1M phosphate buffer (pH 6.6), and 0.5 g of potassium ferricyanide was added and mixed.

혼합액을 50℃에서 30분간 반응시켰고 10% 트리클로로 아세트산 (trichloroacetic acid, 50 ml, 5 g)을 첨가하여 혼합하였다.The mixture was reacted at 50° C. for 30 minutes, and 10% trichloroacetic acid (trichloroacetic acid, 50 ml, 5 g) was added and mixed.

혼합액 100 ul에 증류수 100 ul와 0.1% 염화제2철 (ferric chloride, 10 ml, 0.01 g)을 첨가하여 Cytation-3 마이크로플레이트 리더를 사용하여 700 nm 파장에서 흡광도를 측정하였다. 100 ul of distilled water and 0.1% ferric chloride (10 ml, 0.01 g) were added to 100 ul of the mixed solution, and the absorbance was measured at a wavelength of 700 nm using a Cytation-3 microplate reader.

대표적 항산화제인 아스코르빈산 (ascorbic acid) 100 ug/ml을 양성대조군, 달맞이꽃 추출물을 실험군으로 하였다.100 ug/ml of ascorbic acid, a representative antioxidant, was used as a positive control, and evening primrose extract was used as an experimental group.

아스코르빈산이 Fe3+/페리시안화합물 (ferric cyanide) 복합체를 Fe2+ 형태로 환원한 정도를 100%로 놓고 달맞이꽃 추출물의 환원력을 분석하였다.The reducing power of the evening primrose extract was analyzed by setting the degree of reduction of ascorbic acid to Fe 3+ / ferric cyanide complex to Fe 2 + form at 100%.

도 2(a)는 달맞이꽃 추출물의 환원력을 나타낸 그래프이다.Figure 2 (a) is a graph showing the reducing power of the evening primrose extract.

그 결과, 달맞이꽃 추출물의 환원력은 농도 의존적으로 증가하였고, 60 ug/ml의 농도에서 가장 높은 환원력을 보였다.As a result, the reducing power of the evening primrose extract increased in a concentration-dependent manner, and showed the highest reducing power at a concentration of 60 ug/ml.

2) 달맞이꽃 추출물의 DPPH 라디칼 소거능 분석2) DPPH radical scavenging activity analysis of evening primrose extract

달맞이꽃 추출물의 2,2-디페닐-1-피크릴하이드라질 (2,2-Diphenyl-1-picrylhydrazyl, DPPH) 라디칼 소거능을 분석하기 위해, 달맞이꽃 추출물 (0~100 ug/ml) 100 ul에 DHHP 라디칼 (최종농도 0.2 mM)가 포함된 메탄올 용액 100 ul를 첨가하여 혼합하였다.To analyze the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity of evening primrose extract, DHHP in 100 ul of evening primrose extract (0-100 ug/ml) 100 ul of a methanol solution containing radicals (final concentration 0.2 mM) was added and mixed.

혼합액을 25℃에서 30분간 반응시킨 뒤, 분광광도계를 사용하여 517 nm 파장에서 혼합액의 흡광도를 측정하였다.After reacting the mixed solution at 25° C. for 30 minutes, the absorbance of the mixed solution was measured at a wavelength of 517 nm using a spectrophotometer.

대표적 항산화제인 아스코르빈산 (ascorbic acid) 100 ug/ml을 양성대조군, 달맞이꽃 추출물을 실험군으로 하였다.100 ug/ml of ascorbic acid, a representative antioxidant, was used as a positive control, and evening primrose extract was used as an experimental group.

도 2(b)는 달맞이꽃 추출물의 DPPH 라디칼 소거능을 나타낸 그래프이다.2(b) is a graph showing the DPPH radical scavenging activity of the evening primrose extract.

그 결과, 달맞이꽃 추출물의 DPPH 라디칼 소거능은 농도 의존적으로 증가하였고, 60 ug/ml의 농도에서 가장 높은 소거능을 보였다.As a result, DPPH radical scavenging activity of evening primrose extract increased in a concentration dependent manner, and the highest scavenging activity was shown at a concentration of 60 ug/ml.

실험예 4. 달맞이꽃 추출물을 처리한 세포의 ROS 생산정도 측정Experimental Example 4. Measurement of ROS production level of cells treated with evening primrose extract

세포 내 활성산소종 (reactive oxygen species, ROS)의 생산정도를 측정하기 위해 산화민감염료인 2′,7′-dichlorodihydrofluorescein diacetate (DCF-DA)를 사용하였다.To measure the level of production of reactive oxygen species (ROS) in cells, 2′,7′-dichlorodihydrofluorescein diacetate (DCF-DA), an oxidation-sensitive agent, was used.

배양된 HaCaT 세포에 인산완충식염수 (phosphate-buffered saline, PBS)로 2번 워싱한 후, 10 uM DCF-DA를 첨가한 뒤 37℃에서 30분간 암실에서 반응시켰다.After washing the cultured HaCaT cells twice with phosphate-buffered saline (PBS), 10 uM DCF-DA was added and reacted at 37° C. for 30 minutes in the dark.

반응액을 PBS로 워싱한 뒤, FL-1 형광을 유세포측정기 (FACS Calibur)로 측정하였다.After washing the reaction solution with PBS, FL-1 fluorescence was measured with a flow cytometer (FACS Calibur).

아무것도 처리되지 않은 세포를 정상군, 달맞이꽃 추출물 60 ug/ml만 처리한 세포를 대조군 1, NAC 10 mM만 처리한 세포를 대조군 2, 과산화수소 0.5 mM을 처리한 세포를 양성대조군, NAC 10 mM을 처리한 뒤 과산화수소 0.5 mM을 처리한 세포를 음성대조군, 달맞이꽃 추출물 60 ug/ml을 처리한 뒤 과산화수소 0.5 mM을 처리한 세포를 실험군으로 정하였다.Control 1 for cells treated with only 60 ug/ml of evening primrose extract, control 2 for cells treated with only 10 mM NAC, positive control for cells treated with 0.5 mM hydrogen peroxide, and 10 mM NAC After that, the cells treated with 0.5 mM hydrogen peroxide were treated with a negative control and 60 ug/ml of evening primrose extract, and then the cells treated with 0.5 mM hydrogen peroxide were designated as the experimental group.

도 3은 달맞이꽃 추출물이 과산화수소를 처리하여 산화 스트레스를 유도한 HaCaT 세포의 활성산소종 생산에 미치는 효과를 나타낸 도면으로, (a)는 HaCaT 세포의 활성산소종 생산정도를 나타낸 현광현미경 사진이고 (200배율), (b) 활성산소종의 생산정도를 유세포측정기로 측정한 결과를 나타내는 그래프이고, (c)는 현광현미경에서 측정된 형광발현정도를 나타낸 그래프이고, (d)는 활성산소종의 생산정도를 나타낸 그래프이다.Figure 3 is a view showing the effect of the evening primrose extract on the production of reactive oxygen species in HaCaT cells induced oxidative stress by treatment with hydrogen peroxide, (a) is a photomicrograph showing the level of reactive oxygen species production in HaCaT cells (200 Magnification), (b) is a graph showing the result of measuring the production level of reactive oxygen species with a flow cytometer, (c) is a graph showing the degree of fluorescence expression measured by a fluorescence microscope, and (d) is the production of reactive oxygen species It is a graph showing the degree.

그 결과, 30분동안 과산화수소를 처리한 양성대조군은 세포내 활성산소종 생산에 상당한 증가를 보인 반면에, NAC를 전처리한 음성대조군 및 달맞이꽃 추출물을 전처리한 실험군에서는 활성산소종 생산이 억제되었다.As a result, the positive control treated with hydrogen peroxide for 30 minutes showed a significant increase in the production of intracellular reactive oxygen species, whereas the negative control pretreated with NAC and the experimental group pretreated with evening primrose extract suppressed the production of reactive oxygen species.

실험예 5. comet assay를 이용한 달맞이꽃 추출물을 처리한 세포의 DNA 손상정도 측정Experimental Example 5. Measurement of DNA damage in cells treated with evening primrose extract using comet assay

코밋 어세이 (comet assay)는 단일세포전기영동법 (single cell gel electrophoresis assay)을 이용하여 세포에 DNA 손상정도를 측정하는 실험법이다.The comet assay is an experimental method that measures the degree of DNA damage to cells by using a single cell gel electrophoresis assay.

세포가 손상되면 DNA 이중가닥이 절단되어 파편이 생기는데 그 파편이 생긴 흔적이 혜성 (comet)이 지나가는 모양과 흡사하다.When the cell is damaged, the double strands of DNA are cut to form fragments, and the traces of the fragments resemble the shape of a comet passing by.

DNA 분자량의 크기가 작을수록 핵으로부터 멀리 이동되므로 손상되어 잘려진 DNA 가닥이 많을수록 혜성 꼬리처럼 긴 모양이 생긴다.The smaller the molecular weight of the DNA is, the farther it is from the nucleus, so the more damaged and cut DNA strands, the longer a comet tail is formed.

달맞이꽃 추출물이 과산화수소를 30분동안 처리하여 산화 스트레스를 유도한 HaCaT 세포의 DNA 손상에 미치는 영향을 분석하기 위해, 코밋 어세이를 수행하였다.In order to analyze the effect of the evening primrose extract on the DNA damage of HaCaT cells induced oxidative stress by treating hydrogen peroxide for 30 minutes, a Comet assay was performed.

달맞이꽃 추출물을 처리한 HaCaT 세포를 PBS로 워싱한 뒤, 0.5% 아가로오스 젤 (agarose gel)과 혼합하였다.HaCaT cells treated with evening primrose extract were washed with PBS, and then mixed with 0.5% agarose gel.

슬라이드 글라스 (slide glass)에 1% 아가로스 젤로 코팅된 슬라이드 글라스에 혼합액을 올려준 뒤 커버 글라스 (cover glass)로 덮어 4℃에서 10분간 보관하였다.The mixture was put on a slide glass coated with 1% agarose gel on a slide glass, covered with a cover glass, and stored at 4°C for 10 minutes.

젤이 굳은 후, 커버글라스를 제거하고 다시 0.5% 아가로오스 젤을 슬라이드 위에 떨어뜨린 후, 4℃에서 40분간 보관하였다. After the gel was hardened, the cover glass was removed, and 0.5% agarose gel was dropped on the slide, and then stored at 4° C. for 40 minutes.

젤이 굳은 것을 확인하고 용해완충용액 (2.5 M NaCl 및 500 mM Na-ethylene diamine tetra acetic acid (EDTA))와 1% 트리톤 (triton) X-100을 섞어 커버 글라스를 벗긴 슬라이드 슬라이드 글라스를 담가 4℃에서 1시간 동안 침지시켜 주었다.After confirming that the gel is solid, mix the solution buffer solution (2.5 M NaCl and 500 mM Na-ethylene diamine tetra acetic acid (EDTA)) and 1% triton X-100, and immerse the slide glass with the cover glass removed. It was immersed in for 1 hour.

이어서, DNA의 이중가닥을 풀기위해 언와인딩 (unwinding) 완충용액 (300 mM NaOH, 10 mM Na2EDTA, pH 13)에 슬라이드 글라스를 침지시킨 뒤 전기영동 탱크에 슬라이드 글라스를 옮겼다.Then, the slide glass was immersed in an unwinding buffer solution (300 mM NaOH, 10 mM Na 2 EDTA, pH 13) to unwind the double strands of DNA, and then the slide glass was transferred to an electrophoresis tank.

그런 다음, 25 V/300 mA의 전압에서 20분간 전기영동 하였다.Then, electrophoresis was performed for 20 minutes at a voltage of 25 V/300 mA.

전기영동이 끝난 뒤, 슬라이드를 25℃에서 5분동안 0.4 M Tris (pH 7.5)으로 3회 워싱하고, 20 ug/ml 요오드화 프로피듐 (propidium iodide, PI)으로 염색하고, 형광현미경 (Carl Zeiss)으로 관찰하였다.After electrophoresis was completed, the slide was washed 3 times with 0.4 M Tris (pH 7.5) for 5 minutes at 25°C, stained with 20 ug/ml propidium iodide (PI), and a fluorescence microscope (Carl Zeiss) Was observed.

아무것도 처리되지 않은 세포를 정상군, 달맞이꽃 추출물 60 ug/ml만 처리한 세포를 대조군 1, 과산화수소 0.5 mM을 처리한 세포를 양성대조군, NAC 10 mM을 처리한 뒤 과산화수소 0.5 mM을 처리한 세포를 음성대조군, 달맞이꽃 추출물 60 ug/ml을 처리한 뒤 과산화수소 0.5 mM을 처리한 세포를 실험군으로 정하였다.The cells treated with nothing were normal, cells treated with only 60 ug/ml of evening primrose extract were treated as control 1, cells treated with 0.5 mM hydrogen peroxide were positive control, and cells treated with 10 mM NAC and then 0.5 mM hydrogen peroxide were negative. A control group, treated with 60 ug/ml of evening primrose extract, and then treated with 0.5 mM hydrogen peroxide, was designated as an experimental group.

*도 4는 달맞이꽃 추출물이 과산화수소를 처리하여 산화 스트레스를 유도한HaCaT 세포의 comet 생성에 미치는 영향을 나타낸 도면으로, (a)는 comet의 생성정도를 나타낸 현광현미경 사진이며, (b)는 comet 꼬리의 운동 (tail moment, TM)을 측정한 그래프이며, (c)는 comet 꼬리의 길이 (tail length, TL)를 측정한 그래프이다.* Figure 4 is a diagram showing the effect of the evening primrose extract on the comet generation of HaCaT cells that induce oxidative stress by treating hydrogen peroxide, (a) is a fluorescence micrograph showing the degree of comet generation, (b) is a comet tail It is a graph measuring the motion (tail moment, TM), and (c) is a graph measuring the length of the comet tail (tail length, TL).

그 결과, 과산화수소를 처리한 양성대조군의 꼬리 길이와 꼬리 운동값이 증가하였지만, NAC를 전처리한 음성대조군과 달맞이꽃 추출물을 전처리한 실험군의 꼬리 길이와 꼬리 운동값은 감소하였다. As a result, the tail length and tail motion values of the positive control treated with hydrogen peroxide increased, but the tail length and tail motion values of the negative control pretreated with NAC and the experimental group pretreated with evening primrose extract decreased.

이에 따라, 달맞이꽃 추출물이 DNA 손상을 억제한다는 것을 확인할 수 있었다.Accordingly, it was confirmed that the evening primrose extract inhibits DNA damage.

실험예 6. 달맞이꽃 추출물을 처리한 세포의 단백질 추출 후 western blot 분석Experimental Example 6. Western blot analysis after protein extraction of cells treated with evening primrose extract

과산화수소 처리된 세포는 산화 스트레스를 받게되고, 세포내 활성산소종이 생성되며, 생성된 활성산소종이 DNA 이중가닥을 절단한다.Hydrogen peroxide-treated cells are subjected to oxidative stress, intracellular reactive oxygen species are generated, and the generated reactive oxygen species cleave DNA double strands.

이 때, DNA의 이중가닥을 유지시켜주는 단백질인 히스톤 단백질 γH2AX가 인산화 (phosphorylation)되며, γH2AX 단백질이 인산화되는 정도를 분석하여 DNA 손상정도를 판단할 수 있다.At this time, the histone protein γH2AX, a protein that maintains the double strands of DNA, is phosphorylated, and the degree of phosphorylation of the γH2AX protein can be analyzed to determine the degree of DNA damage.

또한, 세포가 산화 스트레스를 받아 활성산소종을 생성하게 되면 세포에 손상을 야기하고, 야기된 손상이 복구되기 힘들 정도로 심각하면 세포사멸이 일어나게 된다.In addition, when the cells are subjected to oxidative stress to generate reactive oxygen species, damage to the cells is caused, and if the damage caused is severe enough to be difficult to repair, apoptosis occurs.

세포사멸이 진행되면, 세포사멸 인자가 활성화되면 불필요한 세포의 단백질을 분해하기 위해 단백질 분해효소인 캐스페이즈-3 (caspase-3)과 폴리(ADP-리보오스) 중합효소 (poly(ADP-ribose) polymerase, PARP)가 활성화된다.When apoptosis progresses, when apoptosis factor is activated, proteolytic enzymes caspase-3 and poly(ADP-ribose) polymerase are used to degrade unnecessary cell proteins. , PARP) is activated.

caspase-3 및 PARP 활성화정도에 따라 세포사멸의 정도를 판단할 수 있다.The degree of apoptosis can be determined according to the degree of caspase-3 and PARP activation.

또한, 세포가 산화 스트레스를 받게 되면 Kelch-like ECH-associated protein 1 (Keap1)의 발현이 증가되고, Nuclear factor erythroid 2-related factor 2 (Nrf2) 및 헴산화효소 (heme oxygenase, HO-1)가 활성화되어 산화 스트레스에 대항하는 항산화 활동을 한다. In addition, when cells are subjected to oxidative stress, the expression of Kelch-like ECH-associated protein 1 (Keap1) is increased, and nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase (HO-1) are released. It is activated and acts as an antioxidant against oxidative stress.

Nrf2 및 HO-1는 세포의 산화 스트레스를 억제하는 항산화 활성에 중요한 역할을 하며, Nrf2 및 HO-1 발현정도에 따라 세포의 산화 스트레스에 대항하는 항산화 활동을 판단할 수 있다.Nrf2 and HO-1 play an important role in antioxidant activity that inhibits oxidative stress in cells, and antioxidant activity against oxidative stress in cells can be judged according to the expression level of Nrf2 and HO-1.

달맞이꽃 추출물이 과산화수소를 30분동안 처리하여 산화 스트레스가 유도된 HaCaT 세포의 DNA 손상, 세포사멸 및 항산화 활성에 미치는 영향을 분석하기 위해, γH2AX, caspase-3, PARP, Keap1, NrF2 및 HO-1 단백질의 발현정도를 측정하였다.To analyze the effect of evening primrose extract on the DNA damage, apoptosis and antioxidant activity of HaCaT cells induced by oxidative stress by treating hydrogen peroxide for 30 minutes, γH2AX, caspase-3, PARP, Keap1, NrF2 and HO-1 proteins The expression level of was measured.

HaCaT 세포에 용해완충용액 (20 mM sucrose, 1 mM EDTA, 20 μM Tris-Cl (pH 7.2), 1 mM 디티오트레이톨 (dithiothreitol, DTT), 10 mM KCl, 1.5 mM MgCl2 및 5 ug/ml 아프로티닌 (aprotinin))을 첨가한 뒤 30분 동안 반응시킨 후, 12,000 rpm에서 20분간 원심분리하여 세포막 성분 등을 제거한 상층액을 얻었다.Lysis buffer solution (20 mM sucrose, 1 mM EDTA, 20 μM Tris-Cl (pH 7.2), 1 mM dithiothreitol, DTT), 10 mM KCl, 1.5 mM MgCl 2 and 5 ug/ml for HaCaT cells Aprotinin) was added and reacted for 30 minutes, and then centrifuged at 12,000 rpm for 20 minutes to obtain a supernatant from which cell membrane components were removed.

상층액을 단백질 추출 키트 (Bio-Rad Protein Assay Kit)를 사용하여 상층액에 존재하는 단백질을 정량하였다.Protein present in the supernatant was quantified using a protein extraction kit (Bio-Rad Protein Assay Kit).

30~50 ug의 용해액 (lysate)을 폴리아크릴아마이드 젤 전기영동 (Poly Acrylamide Gel Electrophoresis, SDS-PAGE)로 분리하여, 이를 폴리비닐리덴 플루오라이드(polyvinylidene fluoride, PVDF) 막으로 전달하였다.30-50 ug of lysate was separated by polyacrylamide gel electrophoresis (SDS-PAGE), and this was transferred to a polyvinylidene fluoride (PVDF) membrane.

발현정도를 확인하려는 단백질과 결합하는 1차 항체 및 2차 항체를 처리한 뒤 enhanced chemiluminescence (ECL, Amersham Corp) 용액을 처리한 뒤 X-ray 필름에 감광하였다.After treatment with the primary antibody and secondary antibody binding to the protein for which the expression level is to be checked, enhanced chemiluminescence (ECL, Amersham Corp) solution was treated, and then photosensitized on an X-ray film.

*대조군과 실험군은 실험예 6과 동일하게 설정하였다.* The control group and the experimental group were set in the same manner as in Experimental Example 6.

도 5는 달맞이꽃 추출물이 과산화수소를 처리하여 산화 스트레스를 유도한 HaCaT 세포의 단백질 발현에 미치는 영향을 나타낸 도면으로, (a)는 γH2AX 및 인산화된 γH2AX의 발현정도를 나타낸 전기영동 사진이며, (b)는 γH2AX 발현정도에 따른 인산화된 γH2AX 단백질의 비율의 변화를 나타낸 그래프이며, (c)는 caspase-3 및 PARP의 활성화정도를 나타낸 전기영동 사진이며, (d)는 달맞이꽃 추출물의 처리 시간에 따른 keap1, Nrf2 및 HO-1의 발현정도를 나타낸 전기영동 사진이다.5 is a view showing the effect of the evening primrose extract on the protein expression of HaCaT cells induced oxidative stress by treatment with hydrogen peroxide, (a) is an electrophoresis picture showing the expression level of γH2AX and phosphorylated γH2AX, (b) Is a graph showing the change in the ratio of phosphorylated γH2AX protein according to the level of γH2AX expression, (c) is an electrophoresis picture showing the degree of activation of caspase-3 and PARP, and (d) is keap1 according to the treatment time of the evening primrose extract. , Is an electrophoresis picture showing the expression level of Nrf2 and HO-1.

그 결과, 과산화수소를 처리한 양성대조군은 γH2AX의 인산화가 증가하였으므로 DNA가 손상된 것을 알 수 있었으며, caspase-3 및 PARP가 활성화되어 세포사멸이 진행되고 있는 것을 알 수 있었다.As a result, the positive control treated with hydrogen peroxide increased phosphorylation of γH2AX, indicating that DNA was damaged, and that caspase-3 and PARP were activated, leading to apoptosis.

그러나, NAC를 전처리한 음성대조군과 달맞이꽃 추출물을 전처리한 실험군은 γH2AX의 인산화가 감소하였으므로 DNA가 손상이 억제된 것을 알 수 있었으며, caspase-3 및 PARP가 활성화되지 않아 세포사멸이 억제 된 것을 알 수 있었다.However, in the negative control pretreated with NAC and the experimental group pretreated with evening primrose extract, it was found that the phosphorylation of γH2AX was reduced, so DNA damage was suppressed, and apoptosis was suppressed because caspase-3 and PARP were not activated. there was.

또한, 달맞이꽃 추출물의 처리 시간에 따라 Nrf2 및 HO-1의 발현이 증가되었으므로 항산화 활동이 활발한 것을 알 수 있었다.In addition, since the expression of Nrf2 and HO-1 was increased according to the treatment time of the evening primrose extract, it was found that antioxidant activity was active.

실험예 7. 달맞이꽃 추출물을 처리한 세포의 미토콘드리아 막 포텐셜 분석Experimental Example 7. Mitochondrial membrane potential analysis of cells treated with evening primrose extract

활성산소종은 세포 내 미토콘드리아를 공격하여 손상을 야기한다.Reactive oxygen species attack the mitochondria in cells and cause damage.

미토콘드리아에 손상이 야기되면 미토콘드리아 막 포텐셜 (mitochondrial membrane potential, MMT)이 변하는 탈분극 상태가 되는데, 탈분극 정도를 분석하여 미토콘드리아의 손상정도를 측정할 수 있다.When damage to the mitochondria is caused, the mitochondrial membrane potential (MMT) changes to a depolarization state, and the degree of damage to the mitochondria can be measured by analyzing the degree of depolarization.

미토콘드리아 막 포텐셜을 알아보기 위해 JC-1이라는 형광염료를 사용할 수 있다.To determine the mitochondrial membrane potential, a fluorescent dye called JC-1 can be used.

JC-1은 세포사멸이 일어나지 않은 세포에서는 JC-1이 응집체 형태로 결합되어 붉은색 형광을 띄는 반면에, 세포사멸이 일어나는 세포에서는 JC-1이 단량체로 결합되어 붉은색의 형광이 감소하고 녹색 형광이 증가하게 된다.In the case of JC-1, in cells where apoptosis has not occurred, JC-1 is bound in the form of an aggregate and exhibits red fluorescence, whereas in cells where apoptosis occurs, JC-1 is bound as a monomer, reducing red fluorescence and green color. Fluorescence increases.

이러한 붉은색 형광과 녹생 형광의 발현의 변화를 통해, 미토콘드리아 막 포텐셜의 변화를 측정하여 세포사멸 정도를 분석할 수 있다.Through the change in expression of red fluorescence and green fluorescence, the degree of apoptosis can be analyzed by measuring the change in mitochondrial membrane potential.

HaCaT 세포를 배양한 뒤, 세포만 모아서 JC-1 (10 ㎍/ml)을 포함하고 있는 인산완충식염수에 현탁하였다. After culturing the HaCaT cells, only the cells were collected and suspended in phosphate buffered saline containing JC-1 (10 μg/ml).

37℃에서 15분 동안 반응시킨 뒤, 세포만 모아서 인산완충식염수에 현탁하여 유세포측정기를 사용하여 측정하였다.After reacting at 37° C. for 15 minutes, only cells were collected, suspended in phosphate buffered saline, and measured using a flow cytometer.

대조군과 실험군은 실험예 6과 동일하게 설정하였다.The control group and the experimental group were set in the same manner as in Experimental Example 6.

도 6은 달맞이꽃 추출물이 과산화수소를 처리하여 산화 스트레스를 유도한 HaCaT 세포의 미토콘드리아 막 전위에 미치는 영향을 나타낸 도면으로, (a)는 JC-1 응집체가 JC-1 단량체로 변하는 정도를 유세포측정기로 측정하여 나타낸 그래프이며, (b)는 JC-1 응집체가 JC-1단량체로 변하면서 달라지는 붉은색 형광값을 나타낸 그래프이다.6 is a view showing the effect of the evening primrose extract on the mitochondrial membrane potential of HaCaT cells induced oxidative stress by treating hydrogen peroxide.(a) is a flow cytometer measuring the degree to which the JC-1 aggregate changes to the JC-1 monomer. And (b) is a graph showing the red fluorescence value that changes as the JC-1 aggregate changes to the JC-1 monomer.

그 결과, 과산화수소를 처리한 양성대조군은 미토콘드리아 막이 손상되어 전위의 변화가 일어났으며 (탈분극), JC-1의 붉은색 형광값이 감소하였고 녹색 형광값이 증가하였다.As a result, in the positive control treated with hydrogen peroxide, the mitochondrial membrane was damaged, resulting in a change in potential (depolarization), the red fluorescence value of JC-1 decreased, and the green fluorescence value increased.

그러나, NAC를 전처리한 음성대조군과 달맞이꽃 추출물을 전처리한 실험군의 미토콘드리아 막의 전위의 변화가 관찰되지 않았으며, JC-1의 붉은색 형광값은 정상군의 값과 유사하였다.However, no change in mitochondrial membrane potential was observed in the negative control group pretreated with NAC and the experimental group pretreated with evening primrose extract, and the red fluorescence value of JC-1 was similar to that of the normal group.

실험예 8. 달맞이꽃 추출물을 처리한 세포의 사멸정도 분석Experimental Example 8. Analysis of the degree of death of cells treated with evening primrose extract

활성산소종은 세포의 손상을 야기하여 세포사멸 (apoptosis)을 유도한다.Reactive oxygen species cause damage to cells and induce apoptosis.

정상세포의 세포막 내에는 포스파티딜세린 (phosphatidylserine)이라는 단백질이 존재하는데, 세포사멸이 유도된 세포는 세포막의 안과 밖이 뒤집혀 세포막 내에 있어야 할 포스파티딜세린이 세포막 밖에 존재하게 된다.In the cell membrane of normal cells, a protein called phosphatidylserine exists, and in cells in which apoptosis is induced, the inside and outside of the cell membrane are turned over, and the phosphatidylserine, which should be in the cell membrane, exists outside the cell membrane.

이때, 포스파티딜세린과 결합하는 형광염료인 아넥신 V (annexin V)를 처리하여 발현되는 형광의 정도를 분석하여 세포사멸의 유무를 측정할 수 있다.At this time, the presence or absence of apoptosis can be measured by analyzing the degree of fluorescence expressed by treatment with annexin V, a fluorescent dye that binds to phosphatidylserine.

달맞이꽃 추출물이 과산화수소를 30분동안 처리하여 산화 스트레스를 유도한 HaCaT 세포의 사멸에 미치는 영향을 알아보기 위해, 아넥신 V-FITC (annexin V-FITC) 세포사멸 검출 키트 (BD Biosciences)를 사용하였다.In order to investigate the effect of evening primrose extract on the death of HaCaT cells induced oxidative stress by treating hydrogen peroxide for 30 minutes, an annexin V-FITC apoptosis detection kit (BD Biosciences) was used.

HaCaT 세포에 달맞이꽃 추출물을 24시간동안 처리한 후 인산완충식염수로 워싱하고 아넥신 (annexin) V와 프로피디움 요오드화물 (propidium iodide, PI)가 혼합된 바인딩 (binding) 버퍼 5 ul를 이용하여 암실의 상온에서 15분간 염색시킨 다음, 염색된 세포는 유세포분석기 (FACS calibur)를 이용하여 사멸세포를 나타내는 아넥신 V 양성 세포들을 측정하였다.After treating HaCaT cells with evening primrose extract for 24 hours, wash with phosphate buffered saline, and use 5 ul of binding buffer mixed with annexin V and propidium iodide (PI) in the dark. After staining for 15 minutes at room temperature, the stained cells were measured for annexin V positive cells indicating dead cells using a flow cytometer (FACS calibur).

대조군과 실험군은 실험예 6과 동일하게 설정하였다.The control group and the experimental group were set in the same manner as in Experimental Example 6.

도 7은 달맞이꽃 추출물이 과산화수소를 처리하여 산화적 스트레스가 유도된 HaCaT 세포의 사멸에 미치는 영향을 나타낸 도면으로, (a)는 4',6'-디아미노-2-페닐인돌 (4',6'-diamidino-2-phenylindol, DAPI)로 염색한 세포 핵을 촬영한 형광현미경 사진이며, (b)는 실험군과 대조군의 세포사멸정도를 측정하여 나타낸 그래프이며, (c) 세포사멸이 유도된 세포의 DNA를 추출하여 전기영동하여 DNA 절단정도를 나타낸 사진이다.7 is a view showing the effect of the evening primrose extract on the death of HaCaT cells induced oxidative stress by treating hydrogen peroxide, (a) is 4',6'-diamino-2-phenylindole (4',6 '-diamidino-2-phenylindol, DAPI) stained cell nucleus is a fluorescence micrograph, (b) is a graph showing the degree of apoptosis in the experimental group and the control group, and (c) apoptosis induced cells This is a picture showing the degree of DNA cleavage by extracting and electrophoresis of DNA.

그 결과, 과산화수소를 처리한 양성대조군은 세포사멸이 유도되어 세포 핵이 파괴된 것을 관찰할 수 있었고, 아넥신 V 양성세포 및 DNA 절단정도가 증가하였다.As a result, in the positive control treated with hydrogen peroxide, apoptosis was induced and cell nuclei were destroyed, and annexin V-positive cells and DNA cleavage were increased.

그러나, NAC를 전처리한 음성대조군과 달맞이꽃 추출물을 전처리한 실험군의 세포 핵은 정상군의 형태와 유사하였으며, 아넥신 V 양성세포 및 DNA 절단정도가 감소하였다.However, the cell nuclei of the negative control group pretreated with NAC and the experimental group pretreated with evening primrose extract were similar to those of the normal group, and annexin V-positive cells and DNA cleavage were decreased.

따라서, 실험예의 결과를 종합해보았을 때, 달맞이꽃 추출물은 세포독성이 없고, 환원력 및 DPPH 라디칼 소거능이 높아 항산화 활성이 뛰어나며, 활성산소종 생산, DNA 손상, 세포사멸 및 미토콘드리아 막 손상을 억제하여 세포의 생존율을 증가시키므로 피부 보호에 효과적인 조성물이라는 것을 확인할 수 있었다. Therefore, when the results of the experimental example are summarized, the evening primrose extract has no cytotoxicity, has excellent antioxidant activity due to high reducing power and DPPH radical scavenging ability, and inhibits the production of reactive oxygen species, DNA damage, apoptosis, and mitochondrial membrane damage. Since it increases the survival rate, it was confirmed that it is an effective composition for skin protection.

실시예 1. 달맞이꽃 추출물을 유효성분으로 함유하는 피부 보호용 화장료 조성물.Example 1. A cosmetic composition for skin protection containing evening primrose extract as an active ingredient.

본 실시예에 따른 조성물은 상기 실험예의 실험 결과에 근거하여, 달맞이꽃 추출물을 유효성분으로 함유하는 피부 보호용 화장료 조성물이다.The composition according to the present embodiment is a cosmetic composition for skin protection containing an evening primrose extract as an active ingredient, based on the experimental results of the experimental example.

유효성분의 농도는 상기 실험예에 근거하여 볼 때, 인간 피부각질세포 (HaCaT) 3 x 105 cells/ml에 50~70 ug/ml인 것이 바람직하다.The concentration of the active ingredient is preferably 50 to 70 ug/ml in 3 x 10 5 cells/ml of human keratinocytes (HaCaT) based on the above experimental examples.

상기 화장료 조성물은 스킨, 스킨 소프트너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐로션, 영양로션, 마사지크림, 영양크림, 아이 크림, 모이스쳐 크림, 핸드크림, 에센스, 영양에센스, 팩, 클렌징폼, 클렌징 워터, 클렌징 로션, 클렌징 크림, 바디로션, 바디클렌져, 비누 및 파우더로 이루어진 군으로부터 선택되는 어느 하나의 제형으로 제조될 수 있다.The cosmetic composition is skin, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nutrition lotion, massage cream, nutrition cream, eye cream, moisture cream, hand cream, essence, nutrition essence, pack, cleansing foam , Cleansing water, cleansing lotion, cleansing cream, body lotion, body cleanser, soap, and powder can be prepared in any one formulation selected from the group consisting of.

본 발명의 화장료 조성물의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라가칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 사용될 수 있다.When the formulation of the cosmetic composition of the present invention is a paste, cream or gel, animal fibers, plant fibers, wax, paraffin, starch, tragacanth, cellulose derivatives, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide as carrier components Etc. can be used.

본 발명의 화장료 조성물의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로 락토스, 탈크, 실리카,알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판-부탄 또는 디메틸에테르와 같은 추진체를 포함할 수 있다.When the formulation of the cosmetic composition of the present invention is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In particular, in the case of a spray, additionally chlorofluorohydro Propellants such as carbon, propane-butane or dimethylether may be included.

본 발명의 화장료 조성물의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로 용매, 용매화제 또는 유탁화제가 이용될 수 있고, 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르 등이 사용될 수 있다.When the formulation of the cosmetic composition of the present invention is a solution or emulsion, a solvent, a solvating agent or an emulsifying agent may be used as a carrier component, and water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, Propylene glycol, 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan may be used.

본 발명의 화장료 조성물의 제형이 현탁액인 경우에는 담체 성분으로 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 사용될 수 있다.When the formulation of the cosmetic composition of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tracant, and the like can be used.

본 발명의 화장료 조성물의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 사용될 수 있다.When the formulation of the cosmetic composition of the present invention is a surfactant containing cleansing, as a carrier component, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate , Fatty acid amide ether sulfates, alkylamidobetaines, fatty alcohols, fatty acid glycerides, fatty diethanolamides, vegetable oils, linoline derivatives or ethoxylated glycerol fatty acid esters, and the like may be used.

또한, 상기 화장료 조성물은 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온 봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제 또는 지질 소낭 등이 사용될 수 있다.In addition, the cosmetic composition is a fatty substance, an organic solvent, a solubilizing agent, a thickening and gelling agent, an emollient, an antioxidant, a suspending agent, a stabilizer, a foaming agent, a fragrance, a surfactant, water, ionic or nonionic Emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic activators or lipid vesicles, and the like may be used.

실시예 2. 달맞이꽃 추출물을 유효성분으로 함유하는 피부 보호용 건강식품 조성물Example 2. Skin protection health food composition containing evening primrose extract as an active ingredient

본 실시예에 따른 조성물은 상기 실험예의 실험 결과에 근거하여, 달맞이꽃 추출물을 유효성분으로 함유하는 피부 보호용 건강기능식품 조성물이다.The composition according to the present embodiment is a health functional food composition for skin protection containing an evening primrose extract as an active ingredient, based on the experimental results of the experimental example.

유효성분의 농도는 상기 실험예에 근거하여 볼 때, 인간 피부각질세포 (HaCaT) 3 x 105 cells/ml에 50~70 ug/ml인 것이 바람직하다.The concentration of the active ingredient is preferably 50 to 70 ug/ml in 3 x 10 5 cells/ml of human keratinocytes (HaCaT) based on the above experimental examples.

본 발명의 건강기능식품 조성물은 식품 보조 첨가제를 추가하여 식품류, 음료, 껌, 차 또는 비타민 복합제와 같은 건강기능식품을 제조할 수 있다. The health functional food composition of the present invention can prepare a health functional food such as foods, beverages, gum, tea or vitamin complex by adding food supplements.

본 발명의 건강기능식품 조성물은 다른 성분을 사용하는 것에 있어 제한이 없으며, 향미제 또는 천연탄수화물 등을 추가 성분으로 함유할 수 있다.The health functional food composition of the present invention is not limited in the use of other ingredients, and may contain flavoring agents or natural carbohydrates as additional ingredients.

상기 향미제는 타우마틴, 스테비아 추출물, 레바우디오시드 A, 글리시르히진, 사카린 또는 아스파르탐 등을 유리하게 사용할 수 있다.Taumatin, stevia extract, rebaudioside A, glycyrrhizin, saccharin or aspartame may be advantageously used as the flavoring agent.

상기 천연탄수화물은 포도당, 과당, 말토스, 슈크로스, 덱스트린, 시클로덱스트린, 자일리톨, 소르비톨 또는 에리트리톨 등을 사용할 수 있다. As the natural carbohydrate, glucose, fructose, maltose, sucrose, dextrin, cyclodextrin, xylitol, sorbitol, or erythritol may be used.

상기 외에 본 발명의 건강기능식품 조성물은 영양제, 비타민, 광물(전해질), 합성 풍미제, 천연 풍미제, 착색제, 중진제, 펙트산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올 또는 탄산화제 등을 함유할 수 있다.In addition to the above, the health functional food composition of the present invention includes nutrients, vitamins, minerals (electrolytes), synthetic flavors, natural flavors, colorants, heavy agents, pectic acids and salts thereof, organic acids, protective colloid thickeners, pH adjusters, stabilizers. , Preservatives, glycerin, alcohols or carbonation agents.

Claims (1)

달맞이꽃 지상부(aerial part)를 분쇄하여 분말을 얻는 단계;
상기 분말을 에탄올에 넣은 뒤 24시간 동안 100rpm에서 진탕혼합하는 단계; 및
상기 혼합물을 필터를 사용하여 여과한 뒤 용매를 제거하는 단계를 포함하여 구성되는 피부 세포사멸 방지용 화장료 조성물의 제조방법에 있어서,
상기 화장료 조성물의 처리 농도는 인간 피부각질세포 (HaCaT) 3 x 105 cells/ml에 50~70 ug/ml이고,
상기 세포사멸 방지는 DNA의 손상 방지, caspase-3 및 PARP의 불활성화, 미토콘드리아 막 포텐셜의 변화를 억제함으로써 세포사멸을 방지하는 것을 특징으로 하는 피부 세포사멸 방지용 화장료 조성물의 제조방법.


Pulverizing the aerial part of the evening primrose to obtain a powder;
Shaking and mixing the powder at 100 rpm for 24 hours after putting the powder in ethanol; And
In the method for producing a cosmetic composition for preventing skin cell death comprising the step of removing the solvent after filtering the mixture using a filter,
The treatment concentration of the cosmetic composition is 50 to 70 ug/ml in 3 x 10 5 cells/ml of human keratinocytes (HaCaT),
The prevention of apoptosis is a method for producing a cosmetic composition for preventing skin apoptosis, characterized in that preventing apoptosis by preventing DNA damage, inactivating caspase-3 and PARP, and inhibiting a change in mitochondrial membrane potential.


KR1020200091521A 2018-12-05 2020-07-23 Composition for protecting skin containing oenothera biennis extract as active ingredient KR102566548B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020200091521A KR102566548B1 (en) 2018-12-05 2020-07-23 Composition for protecting skin containing oenothera biennis extract as active ingredient

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180154837A KR20200068780A (en) 2018-12-05 2018-12-05 Composition for protecting skin containing oenothera biennis extract as active ingredient
KR1020200091521A KR102566548B1 (en) 2018-12-05 2020-07-23 Composition for protecting skin containing oenothera biennis extract as active ingredient

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020180154837A Division KR20200068780A (en) 2018-12-05 2018-12-05 Composition for protecting skin containing oenothera biennis extract as active ingredient

Publications (2)

Publication Number Publication Date
KR20200107880A true KR20200107880A (en) 2020-09-16
KR102566548B1 KR102566548B1 (en) 2023-08-14

Family

ID=87565727

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200091521A KR102566548B1 (en) 2018-12-05 2020-07-23 Composition for protecting skin containing oenothera biennis extract as active ingredient

Country Status (1)

Country Link
KR (1) KR102566548B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116785214A (en) * 2023-08-01 2023-09-22 海南华研胶原科技股份有限公司 Anti-aging salmon collagen peptide mask and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001233725A (en) * 2000-02-23 2001-08-28 Shin Nippon Yakugyou Kk Cosmetic composition containing polyphenol compound derived from oenothera tetraptera
JP2002308752A (en) * 2001-04-06 2002-10-23 Nikko Chemical Co Ltd Skin care preparation
KR20110107212A (en) * 2010-03-24 2011-09-30 주식회사 에스알테크 Compositions for preventing, ameliorating, or treating symptom of atopic dermatitis
KR20140033480A (en) * 2011-11-28 2014-03-18 계명대학교 산학협력단 Skin condition improving composition comprising extract from oenothera laciniata hill as active ingredient
KR20170028671A (en) * 2015-09-04 2017-03-14 바이오스펙트럼 주식회사 Composition for prevention or ameliorating of allergic diseases comprising Oenothera odorata extract
KR20180103256A (en) * 2017-03-09 2018-09-19 송석주 Cosmetic composition including oenothera biennis flower extract

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001233725A (en) * 2000-02-23 2001-08-28 Shin Nippon Yakugyou Kk Cosmetic composition containing polyphenol compound derived from oenothera tetraptera
JP2002308752A (en) * 2001-04-06 2002-10-23 Nikko Chemical Co Ltd Skin care preparation
KR20110107212A (en) * 2010-03-24 2011-09-30 주식회사 에스알테크 Compositions for preventing, ameliorating, or treating symptom of atopic dermatitis
KR20140033480A (en) * 2011-11-28 2014-03-18 계명대학교 산학협력단 Skin condition improving composition comprising extract from oenothera laciniata hill as active ingredient
KR20170028671A (en) * 2015-09-04 2017-03-14 바이오스펙트럼 주식회사 Composition for prevention or ameliorating of allergic diseases comprising Oenothera odorata extract
KR101892626B1 (en) 2015-09-04 2018-08-28 바이오스펙트럼 주식회사 Composition for prevention or ameliorating of allergic diseases comprising Oenothera odorata extract
KR20180103256A (en) * 2017-03-09 2018-09-19 송석주 Cosmetic composition including oenothera biennis flower extract

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116785214A (en) * 2023-08-01 2023-09-22 海南华研胶原科技股份有限公司 Anti-aging salmon collagen peptide mask and preparation method thereof

Also Published As

Publication number Publication date
KR102566548B1 (en) 2023-08-14

Similar Documents

Publication Publication Date Title
Phrueksanan et al. Protection of Clitoria ternatea flower petal extract against free radical-induced hemolysis and oxidative damage in canine erythrocytes
KR101333209B1 (en) Cosmetic composition for preventing skin aging comprising surface-modified gold nanoparticle by phytochemical
CN109199878A (en) A kind of whitening sun protection W/O/W multiple emulsion and preparation method thereof
TW201731487A (en) Anti-pollution complex comprising calendula extracts and an aqueous extract of Lilium candidum bulb and uses thereof
Câmara et al. Behind the scenes of anthocyanins—From the health benefits to potential applications in food, pharmaceutical and cosmetic fields
Asadpour et al. Water-soluble compounds of lettuce inhibit DNA damage and lipid peroxidation induced by glucose/serum deprivation in N2a cells
KR101839491B1 (en) Extraction Method of Houttuynia cordata Thunberg Extract and Cosmetic materials Using the same
KR102566548B1 (en) Composition for protecting skin containing oenothera biennis extract as active ingredient
KR102063686B1 (en) Skin external composition containing extract of soybean root
JP6077560B2 (en) Skin external preparation composition containing white-bellied extract
CN106572967A (en) Lightening active agent containing plant extracts, uses thereof and compositions containing same
KR20200068780A (en) Composition for protecting skin containing oenothera biennis extract as active ingredient
JP7232642B2 (en) Anti-aging method and anti-aging agent
Lee et al. Evaluation of Alcea rosea L. callus extract as a natural cosmetic ingredient
KR101718190B1 (en) Composition for protecting or curing human keratinocyte against UVB containing Extract of Carpomitra costata Stackhouse Batters as an active ingredient
ES2553055T3 (en) Dermocosmetic compositions based on a synergistic association of colloidal silver and deoxyribonucleic acid
ES2274163T3 (en) PREPARATION FOR APPLICATION (I) ORAL AND / OR TOPICS.
KR20200064384A (en) Cosmetic composition of antioxidant, anti-inflammatory containing artemisia princeps pampanini
KR101445642B1 (en) Cosmetic composition comprising the extract of Lagerstroemia indica as active ingredient
JP3889894B2 (en) Antiallergic agents, whitening agents and skin cosmetics
JP2011168543A (en) Singlet oxygen scavenger, and skin care external preparation and cosmetic each using the singlet oxygen scavenger
JP2010150173A (en) Skin whitening agent, melanogenesis inhibitor, and skin whitening skin external preparation
KR102255036B1 (en) Antioxidant and skin anti-pollution composition containing evening primrose EXTRACT
KR20120004021A (en) Cosmetic composition comprising extracts of cultured wild ginseng root encapsulated in liposome and preparation method thereof
KR101216151B1 (en) The composition for cosmetics containing extracts of Lithospermum erythrorhizon and Angelica gigas Nakai

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant